Skip to main content
. 2026 Feb 9;18(4):554. doi: 10.3390/cancers18040554
ADT Androgen deprivation therapy
ARPI Androgen receptor pathway inhibitor
ATC Anatomical therapeutic chemical classification
BMI Body mass index
CI Confidence interval
CRPC Castration-resistant prostate cancer
EAU European Association of Urology
EMA European Medicines Agency
EMR Electronic medical records
ESMO European Society for Medical Oncology
HSPC Hormone-sensitive prostate cancer
ICD International Classification of Diseases
IQR Interquartile range
L Line (treatment line)
m Metastatic
mCRPC Metastatic castration-resistant prostate cancer
mHSPC Metastatic hormone-sensitive prostate cancer
nm Non-metastatic
nmCRPC Non-metastatic castration-resistant prostate cancer
OS Overall survival
PC Prostate cancer
PSA Prostate-specific antigen
Q1 First quartile
Q3 Third quartile
RECORD REporting of studies Conducted using Observational Routinely-collected health Data
RT Radiotherapy
SD Standard deviation
SEOM Sociedad Española de Oncología Médica
T Tumor
TNM Tumor, node, and metastasis classification
TURP Transurethral resection of the prostate